Computational fragment-based approaches are widely used in drug design and discovery. One of their limitations is the lack performance docking methods, mainly scoring functions. With emergence for single-stranded RNA ligands, we analyze screening powers an MCSS-based approach. The evaluated on a benchmark protein–nucleotide complexes where four residues as fragments. power can be considered maj...